AXL and melanoma: Additionally, two cell surface tyrosine kinase receptors constitutively expressed in melanoma cells, AXL (tyrosine-protein kinase receptor UFO) and c-Met (mesenchymal–epithelial transition factor) [23], were also downregulated by either dabrafenib or AZ628 in the parental cell populations (Figure 5).